AUERBACH ALAN H 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Jul 10, 2025
Insider Transaction Report
Form 4
AUERBACH ALAN H
DirectorPresident and CEO10% Owner
Transactions
- Sale
Common Stock
2025-07-09$3.54/sh−21,580$76,285→ 7,180,901 total - Sale
Common Stock
2025-07-08$3.53/sh−25,592$90,417→ 7,202,481 total
Footnotes (1)
- [F1]Adoption date of referenced 10b5-1(c) plan is: 12-17-2020